SCHEMBL1064604

SCHEMBL1064604

COc1ccc[c]c1OC(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA12 O43570 1/20 0.38
CA4 P22748 1/20 0.38
CA14 Q9ULX7 1/20 0.38
KCNK3 O14649 1/20 0.35
KCNK9 Q9NPC2 1/20 0.35
GRIN2B Q13224 1/20 0.34
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TSHR P16473 2/20 0.33
HTT P42858 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 4/20 0.32
TP53 P04637 2/20 0.32
ADRA2B P18089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622920 0.86 DDB1 (0.34) GAAALDH1A1L3MBTL1KDM4E
SCHEMBL1067882 0.85 KCNK3 (0.35) CA1CA2CA7CA9CA12
SCHEMBL17046331 0.84 KCNH2 (0.31)
SCHEMBL17046260 0.81 KCNK3 (0.40) KCNK3KCNK9ALDH1A1
SCHEMBL16956116 0.81 ALDH1A1 (0.38) NPSR1ALDH1A1TDP1L3MBTL1MAPT
SCHEMBL21268343 0.80 AR (0.36) MEN1KMT2ATSHRHTTHSD17B10
SCHEMBL123985 0.80 CA1 (0.48) CA1CA2CA7CA9CA12
SCHEMBL1068899 0.79 SLC22A12 (0.32)
SCHEMBL17046335 0.78 HCRTR1 (0.34) MEN1GAAKMT2AHTTALDH1A1
SCHEMBL28053410 0.78 CA1 (0.46) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737194-B1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER (US) 1999-03-03 EP claimed
US-5854239-A Diazabicyclic neuokinin antagonists PFIZER INC. (US) 1998-12-29 US claimed
EP-0737194-A1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER INC. (US) 1996-10-16 EP claimed
WO-1995018129-A1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER INC. (US) 1995-07-06 WO claimed
US-20200392107-A1 CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 2020-12-17 US disclosed
EP-3747879-A1 CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF Toray Industries, Inc. (JP) 2020-12-09 EP disclosed
EP-2900645-B1 HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-21 EP disclosed
EP-3167716-A1 SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2017-05-17 EP disclosed
US-9585392-B2 3-phenylisoxazolin derivatives with herbicidal action BAYER CROPSCIENCE AG (DE) 2017-03-07 US disclosed
US-20150245615-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION BAYER CROPSCIENCE AG (DE) 2015-09-03 US disclosed
CN-104245689-A Tetrazolinone compounds and its use as pesticides SUMITOMO CHEMICAL CO 2014-12-24 CN disclosed
WO-2011006886-A2 AZOLE COMPOUNDS CARRYING A SULFUR SUBSTITUENT XIV BASF SE (DE) 2011-01-20 WO disclosed
WO-2010149758-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES BASF SE (DE) 2010-12-29 WO disclosed
US-6110919-A Diazabicyclic neurokinin antagonists PFIZER INC. (US) 2000-08-29 US disclosed
EP-0737194-B1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER (US) 1999-03-03 EP disclosed
US-5854239-A Diazabicyclic neuokinin antagonists PFIZER INC. (US) 1998-12-29 US disclosed
EP-0737194-A1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER INC. (US) 1996-10-16 EP disclosed
WO-1995018129-A1 DIAZABICYCLIC NEUROKININ ANTAGONISTS PFIZER INC. (US) 1995-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392107-A1 CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF NPR3, SLC10A1, CNR2 CA1 1526/4885CA2 580/4885CA7 1211/4885
US-20150245615-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION CYP4X1, CBR3, PAOX CA1 571/4885CA2 86/4885CA7 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.